Company Filing History:
Years Active: 2013-2023
Title: Giovanna Pitarresi: Innovator in Ocular Disease Treatments
Introduction
Giovanna Pitarresi is a prominent inventor based in Palermo, Italy. She has made significant contributions to the field of ocular disease treatments through her innovative formulations and nanoparticle systems. With a total of 9 patents, her work focuses on enhancing the delivery of active ingredients for therapeutic purposes.
Latest Patents
One of her latest patents involves nanostructured formulations for the delivery of silibinin and other active ingredients aimed at treating ocular diseases. These formulations incorporate silibinin in lipid nanoparticle systems, which may include mucoadhesive calixarenes or micellar systems based on amphiphilic inulin copolymers. This versatility allows for the treatment of neurodegenerative ocular diseases by effectively delivering active ingredients that are typically characterized by low water solubility and low bioavailability.
Another notable patent describes nanoparticles designed for the controlled release of Sorafenib and its derivatives. These polymeric nanoparticles are specifically formulated for use in treating various tumor diseases, including those affecting the kidney, liver, thyroid, colon, breast, pancreas, lungs, and recurrent glioblastoma. The innovative approach to drug delivery in her patents showcases her commitment to advancing medical treatments.
Career Highlights
Giovanna has worked with several organizations, including the Distretto Tecnologico Sicilia Micro E Nano Sistemi and Mero S.r.l. Her experience in these companies has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.
Collaborations
Throughout her career, Giovanna has collaborated with notable professionals in her field, including Gaetano Giammona and Fabio Salvatore Palumbo. These partnerships have further enriched her research and development efforts.
Conclusion
Giovanna Pitarresi stands out as a leading inventor in the realm of ocular disease treatments. Her innovative patents and collaborative efforts reflect her dedication to improving therapeutic options for patients. Her work continues to inspire advancements in medical science and drug delivery systems.